Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0950
0.00 (0.00%)
At close: Mar 20, 2026
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of CAD 15.41 million as of March 20, 2026. Its market cap has increased by 46.15% in one year.
Market Cap
15.41M
Enterprise Value
-223.14K
Revenue
157.68K
Ranking
n/a
PE Ratio
1.94
Stock Price
0.10
Market Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 41.95M to 15.41M, a decrease of -63.25%. That is a compound annual growth rate of -20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 15.41M | 5.56% |
| Dec 31, 2025 | 14.60M | 12.50% |
| Dec 19, 2024 | 12.98M | 6.67% |
| Dec 29, 2023 | 12.17M | 7.14% |
| Dec 30, 2022 | 11.36M | -60.48% |
| Dec 31, 2021 | 28.74M | -31.48% |
| Nov 18, 2021 | 41.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 27.88M |
| Thiogenesis Therapeutics | 26.95M |
| Lobe Sciences | 18.86M |
| Hemostemix | 13.67M |
| Rapid Dose Therapeutics | 13.52M |
| PreveCeutical Medical | 11.96M |
| Quantum BioPharma | 11.93M |
| Pharmala Biotech Holdings | 10.89M |